Natural history of incidental world health organization grade II gliomas

Annals of Neurology

Volumn 68, Issue 5, 2010, Pages 727-733

  Pallud, Johan ^a,b,c   Fontaine, Denys ^c,d   Duffau, Hugues ^c,e   Mandonnet, Emmanuel ^c,f   Sanai, Nader ^g   Taillandier, Luc ^c,h   Peruzzi, Philippe ^c,i   Guillevin, Rémy ^c,j   Bauchet, Luc ^c,e   Bernier, Valérie ^c,k   Baron, Marie Hélène ^c,l   Guyotat, Jacques ^c,m   Capelle, Laurent ^c,j  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Réseau d'Etude des Gliomes ^*  (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g BARROW NEUROLOGICAL INSTITUTE   (United States)

^h Nancy Neurological Hospital   (France)

ⁱ REIMS UNIVERSITY HOSPITAL   (France)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k Centre A Vautrin   (France)

^l UNIVERSITY HOSPITAL OF BESANÇON   (France)

^m HÔPITAL NEUROLOGIQUE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN REGION; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTRAST ENHANCEMENT; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GLIOMA; GROUPS BY AGE; HISTOPATHOLOGY; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIODIAGNOSIS; SEX DIFFERENCE; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; INCIDENTAL FINDINGS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; SEX FACTORS; WORLD HEALTH ORGANIZATION;

EID: 78249266888     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22106     Document Type: Article

References (28)

1. Cavaliere R, Lopes MB, Schiff D., Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 2005; 4: 760 - 770.
2. Olson JD, Riedel E, DeAngelis LM., Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 2000; 54: 1442 - 1448.
3. Pallud J, Mandonnet E, Duffau H, et al. Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 2006; 60: 380 - 383.
4. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002; 20: 2076 - 2084.
5. Wessels PH, Weber WE, Raven G, et al. Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 2003; 2: 395 - 403.
6. Katzman GL, Dagher AP, Patronas NJ., Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999; 282: 36 - 39.
7. Onizuka M, Suyama K, Shibayama A, et al. Asymptomatic brain tumor detected at brain check-up. Neurol Med Chir (Tokyo) 2001; 41: 431 - 434; discussion 435.
8. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357: 1821 - 1828.
9. Weber F, Knopf H., Incidental findings in magnetic resonance imaging of the brains of healthy young men. J Neurol Sci 2006; 240: 81 - 84.
10. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97 - 109.
11. Mandonnet E, Delattre JY, Tanguy ML, et al. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 2003; 53: 524 - 528.
12. Mandonnet E, Pallud J, Clatz O, et al. Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm. Neurosurg Rev 2008; 31: 263 - 269.
13. Pallud J, Capelle L, Taillandier L, et al. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol 2009; 11: 176 - 182.
14. Berger MS, Deliganis AV, Dobbins J, Keles GE., The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994; 74: 1784 - 1791.
15. Bauchet L, Rigau V, Mathieu-Daude H, et al. French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 2007; 84: 189 - 199.
16. Kreth FW, Faist M, Rossner R, et al. Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors. Cancer 1997; 79: 370 - 379.
17. Laws ER, Taylor WF Jr, Clifton MB, Okazaki H., Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984; 61: 665 - 673.
18. Lebrun C, Fontaine D, Ramaioli A, et al. Long-term outcome of oligodendrogliomas. Neurology 2004; 62: 1783 - 1787.
19. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 1997; 15: 1294 - 1301.
20. Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 1997; 15: 3129 - 3140.
21. Piepmeier J, Christopher S, Spencer D, et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 1996; 38: 872 - 878; discussion 878-879.
22. Kamiguchi H, Shiobara R, Toya S., Accidentally detected brain tumors: clinical analysis of a series of 110 patients. Clin Neurol Neurosurg 1996; 98: 171 - 175.
23. Davis FG, Kupelian V, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 2001; 3: 152 - 158.
24. Detsky ME, McDonald DR, Baerlocher MO, et al. Does this patient with headache have a migraine or need neuroimaging ? JAMA 2006; 296: 1274 - 1283.
25. Bauman G, Fisher B, Watling C, et al. Adult supratentorial low-grade glioma: long-term experience at a single institution. Int J Radiat Oncol Biol Phys 2009; 75: 1401 - 1407.
26. Ricard D, Kaloshi G, Amiel-Benouaich A, et al. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol 2007; 61: 484 - 490.
27. Fisher BJ, Naumova E, Leighton CC, et al. Ki-67: a prognostic factor for low-grade glioma ? Int J Radiat Oncol Biol Phys 2002; 52: 996 - 1001.
28. Sanai N, Berger MS., Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008; 62: 753 - 764; discussion 764-756.